chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Symptoms beginning at 7 pm: fever 101, chills, body aches, nausea, right upper am pain. Pain in rt arm still existing as of 11-4-14. Pain level is a 8-10.
As I inserted the needle, I felt some resistance; so I pulled back very slightly on the needle and the patient moved (twitched) more than once. She stated that her hand/fingers were tingling. She said it was better after the immunization was completed. I called her later in the evening to see how she was feeling. She called me the next day and stated that the arm was a little sore around the nerves, but better.
Left arm still sore after vaccination - 2 weeks later. Sore when lifting items and lifting arm over shoulder, shoulder pain.
Initial unsolicited report received from a consumer (patient's husband) on 05-Sep-2017. This case involves a 73-year-old female patient who was vaccinated with a dose of FLUZONE HD (batch number, route and site of administration were reported as unknown, expiration date, dose and dose in series were not reported) on an unspecified date in Oct-2016 in the morning (reported as A.M.). Patient's medical history as preexisting physician diagnosed allergies, birth defects, medical conditions (specify) was reported as the reporter refuses to give allergies or medical conditions and illness at the time of vaccination. Concomitant medications were not reported. On an unknown date in Oct-2016 in the afternoon, few hours following the vaccination, the patient's arms were shaking. She went to the emergency room (ER). Laboratory investigations were not reported. As corrective treatment, the patient was given intravenous (IV) fluids. On an unknown date in Oct-2016, the patient recovered from the event (reported as the shaking stopped). List of documents held by sender: none.
Pt began to not feel well approximately 4 hours after administration.  Patient had a lot of mucus in the chest and felt as though she had to continuously clear her throat.  Patient called PCP and was given and Azithromycin to prevent infection.  Patient is still having symptoms but feels fine.  Patient starting flonase and will follow-up with physician if this continues.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Sep-2021 at 3:12 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 24-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product information was not provided. Treatment information was not provided.
103.6 fever 15 hrs after admin of FLUMIST congestion, eye pain, lt leg pain briefly.
Pt states that left deltoid muscle painful after administered Pneumococcal vaccine on Thursday Oct 4, 2012. Pt states that the pain was noticed about 4 hours after administration. Pt was given a cold pack to put on deltoid muscle and to take OTC Ibuprofen every four hours as needed.
had taste of metal in mouth;w/in 15min got dizzy & nauseous & then clammy;cont thru lunch & by 2PM home, threw up;daily hurt all over, had low grade temp;first few days nauseous & vomited;no energy missed 9 days of work;
extreme sensitivity to light; severe migraines; facial muscle spasms; facial muscle spasms; Extreme stomach pain in upper stomach; This is a spontaneous report from a contactable consumer or other non hcp (patient).  A 37-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot Number: FF8814) via an unspecified route of administration, administered in Arm Left on 22Oct2021 16:00 (age 37-years at the time of vaccination), as single dose for COVID-19 immunization. Medical history included colitis ulcerative, generalised anxiety disorder, panic attack, bipolar hypertension retaining of fluid at times insomnia, patient previously took iodine and experienced drug hypersensitivity, allergy to chemicals, rubber sensitivity. Concomitant medication included sertraline hydrochloride (ZOLOFT), lithium, amitriptyline, quetiapine fumarate (SEROQUEL), metoprolol. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No COVID prior to vaccination. On 23Oct2021 20:30 the patient experienced extreme stomach pain in upper stomach, extreme sensitivity to light, severe migraines, and facial muscle spasms. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 06Apr2020 Nasal Swab, sars-cov-2 test: negative on 16Nov2020 Nasal Swab, sars-cov-2 test: negative on 29Aug2021 Nasal Swab, sars-cov-2 test: negative on 24Sep2021 Blood test done. The outcome of all the events was not recovered.  Follow-Up (01Nov2021): Follow-up attempts are completed. No further information is expected.
History of asthma (rescue inhalers only). On 03/12 had status asthmaticus, fever. Went to primary MD. Remains on asthma inhalers, SOB, on antibiotics, still not able to return to school. Diagnosis - asthma and bronchitis.
Arm pain; Feel fluish; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), INFLUENZA LIKE ILLNESS (Feel fluish) and FATIGUE (Fatigue) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNKNOWN) for COVID-19 vaccination.     Concurrent medical conditions included Myasthenia gravis.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm pain), INFLUENZA LIKE ILLNESS (Feel fluish) and FATIGUE (Fatigue). At the time of the report, PAIN IN EXTREMITY (Arm pain), INFLUENZA LIKE ILLNESS (Feel fluish) and FATIGUE (Fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medicines were reported. No treatment information reported.
Case number PHEH2015US003155, is an initial spontaneous report from a nurse received on 10 Feb 2015. This report refers to a 12 year old patient of an unknown gender. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with MENVEO (batch number: M14071, expiry date: Nov 2015) intramuscularly on 14 Jan 2015. It was reported that the vaccine was frozen with excursion at 0.4 Celsius for 1 hour 16 minutes on 14 Jan 2015, 0.8 C for 36 minutes on 24 Jan 2015 and 0.6 C for 35 minutes on 31 Jan 2015. No adverse event reported following this  medication error.
Sore arms; This is a spontaneous report from a contactable pharmacist (husband) via Medical Information Team. This consumer reported similar events for himself and 1 patient. This is a 2nd of 2 reports. A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route of administration on 27Jan2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, patient experienced a sore arm. The outcome of the event sore arm was unknown.  Information on the lot/batch number has been requested. Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021086111 Same reporter/drug/AE and different patients.
nauseous; throwing up; kicked her in the butt; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nauseous), VOMITING (throwing up) and MUSCULOSKELETAL DISCOMFORT (kicked her in the butt) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     no medical history was reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NAUSEA (nauseous), VOMITING (throwing up) and MUSCULOSKELETAL DISCOMFORT (kicked her in the butt). At the time of the report, NAUSEA (nauseous), VOMITING (throwing up) and MUSCULOSKELETAL DISCOMFORT (kicked her in the butt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medications were not reported. treatment medications were not reported.
Received MMR and TD Vaccines on 06/26/07.Started noticing balds spots in my beared around 08/2008.It started as two bald spots.Visited dermatologist and he confirmed that this is Alopecia and i should see some hair growth in 6 months.By 04/2008 i started seeing some hair growth in the bald spots.But at the same time i started seeing new bald spots in beared.Right now i have two balds spots in beared which has some hair growth and 4 new bald spots in beared.
Used needle 36hrs later right deltoid- red + edematous, warm to touch, tender 2/3rd of upper arm similar to prior rxn with DTaP at 15 months age 9/12/00. Not febrile.
It was reported that a male pt received a TD Adult vaccination on 08/31/2000. Reportedly 2 days after the vaccination the pt developed redness and pain below the injection site. No specifics were provided. From additional info received on 10/31/2000 it was reported that the pt also received a PPD Tubersol skin test. Reportedly the pt recovered from this experience. No further info is expected; this case is closed.
Pt recvd 1 dose of Engerix-B & exp muscle ache & pain;
Reported "feels like unable to get enough oxygen while breathing normally and labored breathing upon exertion," onset 4/15/21.
Almost a week later I developed muscle pains in the same arm- that felt like a muscle spasm. Pain traveled down my arm and made it painful to extend my arm completely. The next day, redness appeared around the area where I received the show and some swelling. The area was warm.
Mother called day after vaccines were given states child is breaking out in heat type rash oven face and entire body. Mother has child shopping advised to go to the Emergency Room. Seen at EOR Dx with possible reaction to the vaccines. (Mother feels it was from a new car seat she had started using that day) Follow up was attempted unable to locate until she came to clinic 9/26/06.
24 hrs AFTER VACCINATION, RASH APPEARED IN STOMACH, BACK, ARMS, AND NECK, BASICALLY FROM THE WAIST UP BUT NOT IN THE FACE.
ACHES; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject experienced aches. The action taken with covid-19 vaccine  was not applicable. The outcome of aches was not reported. This report was non-serious. This case, from the same reporter is linked to 20210539064.
Dizziness beginning approximately 7 days after shot.  Dizziness resulted in difficulty standing up and moving around during normal activities for 24 hours so far.  Condition improved after 24 hours, but not fully returned to normal so far.
Within a few minutes (5-10 minutes post vaccination) of sitting down in the observation area I felt a burning sensation to the right and slightly above the vaccination site. This was followed by random areas on the right arm having numbness, pins and needles, and burning. From the right side the sensations continued to other parts of the body (eyelids, arms, feet, chest, scalp etc). Not a single area of the body is untouched except for maybe the toungue. The areas are roughly 1 cm- a couple of inches in diameter and there is no observable pattern to the areas that feel the sensations. Some of them are pretty painful. The sensations have reduced over days but have not gone away. I am not able to sleep well as a result of having these jolts which feel almost like an electric shock.
SORE ARM; ACHES AND PAINS IN JOINTS; TENDER; This spontaneous report received from a consumer concerned a 67 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient was previously vaccinated with covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown and expiry: unknown) (dose number in series 1), 01 in total was administered, dose was not reported for prophylactic vaccination. On an unspecified date, following vaccination with covid-19 vaccine ad26.cov2.s, she had sore arm and just tender (dose number in series 1). The patient additionally received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 211D21A and expiry: 11-APR-2022) dose was not reported, dose number in series 2, 01 in total was administered on 04-JAN-2022 at left deltoid for prophylactic vaccination. No concomitant medications were reported.  On JAN-2022, the patient experienced tender. On 04-JAN-2022, she had side effects of sore arm, and aches and pains in joints (dose number in series 2), and also stated that her arms still hurt. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from sore arm, and aches and pains in joints, and the outcome of tender was not reported (dose number in series 2). This report was non-serious. This case, involving the same patient is linked to 20220112619. This case, from the same reporter is linked to 20220112654 and 20220112293.
there was a problem with a stent that was put in before his 1st dose of the vaccine; This is a spontaneous report from Pfizer. A non-contactable consumer reported for friend that the male patient of an unspecified age received BNT162B2 (reported as COVID-19 Vaccine), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included stent was put in before his 1st dose of the vaccine. The patient's concomitant medications were not reported.  The patient received 1st dose of COVID vaccine and then ended up in the hospital because there was a problem with a stent that was put in before his 1st dose of the vaccine. He was scheduled to get 2nd dose tomorrow (17Feb2021) but she was trying to reschedule his appointment. The event outcome was unknown.  No follow-up attempts are possible; Information about Lot/batch number cannot be obtained.
This is a spontaneous report from a contactable consumer (patient). A 52-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, Lot Number: EW0168 and expiry date was not provided), via an unspecified route of administration in the left arm on 01May2021 at 11:45 (at the age of 52-years-old) as a single dose for COVID-19 immunization. Medical history included diabetes. Concomitant medications included metformin, pravastatin, losartan and glimepiride. Patient received first dose of BNT162B2 (at age of 52-years-old) for COVID-19 immunization and no reaction on previous exposure to vaccine. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received other medications within 2 weeks of vaccination included metformin, pravastatin, losartan and glimepiride. Patient was not diagnosed with COVID-19, prior vaccination. Patient has not been tested for COVID, Since the vaccination. On 03May2021, patient experienced chills, diarrhea, nausea, vomiting, headache, abdominal pain. The adverse event result in visit to emergency room/ department or urgent care. Patient was hospitalized due to events. Treatment received was Sueros, zofran, lactic acid, CT Scan, promethazine. Lab test included CT Scan: unknown. The outcome of all events was recovered. Follow-up attempts are possible. Further information is expected.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm is hurting) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure abnormal. On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced VACCINATION SITE PAIN (arm is hurting). At the time of the report, VACCINATION SITE PAIN (arm is hurting) had resolved. Not Provided. Patient was reported to be taking medication for blood pressure (not specified). No treatment medications were reported. Patient received the 2nd vaccine-Patient reported that  she did not experience any Adverse Event from the 2nd dose of vaccine. Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Significant Follow-up received- Patient's age added ,added second dose and Outcome was updated.
Flu like symptoms,Influenza like illness; Sickness; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sickness) and INFLUENZA LIKE ILLNESS (Flu like symptoms,Influenza like illness) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TREPROSTINIL SODIUM (TYVASO) inhalation gas for Primary pulmonary hypertension.    Concurrent medical conditions included Pulmonary arterial hypertension. Concomitant products included AMBRISENTAN (LETAIRIS) and TADALAFIL (ADCIRCA) for an unknown indication.   On 26-Jan-2021, the patient started TREPROSTINIL SODIUM (TYVASO) (unknown route) at an unspecified dose. In 2021, TREPROSTINIL SODIUM (TYVASO) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced ILLNESS (Sickness). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms,Influenza like illness). At the time of the report, ILLNESS (Sickness) and INFLUENZA LIKE ILLNESS (Flu like symptoms,Influenza like illness) outcome was unknown. Not Provided          Tyvaso delivered by Tyvaso Inhalation Device (TD-300/A),  The current dose was reported as 18-54 µg (3-9 breaths), four times a day (QID) via inhalation (IH) route.  The events of coughing (cough), headaches (headache), and flushing (flushing). The patient was on IH Tyvaso and coughing during sessions. Coughing was a problem. He also had headaches and flushing for 1-1.5 hours after IH Tyvaso sessions. Side effects were not that bad. Action taken with IH Tyvaso was not reported for the events of cough, headache, and flushing. At the time of reporting, the outcome of cough, headache, and flushing was unknown.  The patient received a booster COVID shot. The booster made the patient sick (flu like symptoms) for an estimation of about 3.5 days.
A physician reported that a 2 month old female received Prevnar, Hib-Titer, Infanrix, IPV and Recombivax-HB vaccines on 9/15/00 as part of a study. On 10/14/00, at the age of 3 months, the child died. The cause of death was presumed to be Sudden Infant Death Syndrome. Both the medical monitor and the investigator agree that Sudden Infant Death Syndrome is not related to vaccine administration. Follow-up information received on 6/22/01, indicated that an autopsy revealed the cause of death as Sudden Infant Death Syndrome. The original assessment remained the same.
Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 5/3/2021 and 5/24/2021. Presented to ED on 1/12/2022 with complaint of shortness of breath, Covid+ on 1/10/22. Admitted for acute hypoxemic respiratoratory failure due to Covid PNA. On arrival O2 sat was 70% requiring Oxymask at 11 L. Treated w/decadron, did not qualified for further covid therapies. Kidney function deteriorated and started on HD. Required higher level of O2 with HFNC. He completed steroid course however his conditions continued to deteriorate. Concern for possible PE as d-dimer was elevated critical condition complicated assessment with V/Q scan and CTA. Family updated, code status changed to DNAR. Patient expired 1/28/2022.
Panic attack; received 2 of COVID vaccine dose, 14 days after the first dose; This is a spontaneous report from a contactable consumer. A 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot Number: FA6780; Expiration Date: Sep2021), via an unspecified route of administration in left arm on 18Jun2021 (Age at Time of Vaccination in Years: 27) as dose 2, single for COVID-19 immunization. Historical vaccine included dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot Number: EW0217; Expiration Date: Sep2021), via an unspecified route of administration in left arm on 04Jun2021 for COVID-19 immunization. Medical history included anaemia. There were no concomitant medications. Other products was not reported. The patient experienced received 2 of covid vaccine dose, 14 days after the first dose on 18Jun2021. Patient wanted to be vaccinated, to go home to their country. Additional Vaccines was not administered on same date of the Pfizer Suspect. AE(s) did not required a visit to emergency room or physician office. In Jun2021, the patient was in the hospital recently but it was for a panic attack due to a paperwork issue as far as the caller knows. Nobody had followed up if there any relation to the vaccine and caller is assuming it is just a panic attack. The patient did not received any other vaccinations within four weeks prior to the first administration date of the suspect vaccine. The outcome of the events was unknown.  Amendment: This follow-up report is being submitted to amend previously reported information: Added event panic attack and upgraded to serious (hospitalization).; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021810425 Same reporter/ drug, different patient/ AE
Urticaria, starting a few hours, post vax, and persistent X 9 days. On 2/2/01, seen by health care professional and treated with Benadryl. No further follow-up.
tooth got infected; felt worst every day; This is a spontaneous report from a contactable consumer. A 92-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown), dose 1 via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient stated that, she had her first Covid shot Wednesday a week ago yesterday. Stated the following Saturday her tooth got infected. Called dentist on Sunday who called pharmacy and got some medication. Stated yesterday had to cut tooth out which was not bothering her. Stated had felt worst every day. Wanted to know if the shot had any effect on the antibiotics that she was taking. The patient was taking Cephalexin. Wanted to know if she was going to get better or does she need to stop taking the antibiotic. The patient experienced tooth got infected and felt worst every day on an unspecified date. Outcome of the event was unknown.  Information about lot/batch number has been requested.